期刊
SCIENTIFIC REPORTS
卷 7, 期 -, 页码 -出版社
NATURE PORTFOLIO
DOI: 10.1038/s41598-017-12833-2
关键词
-
资金
- German Research Foundation [He 1320/18-3, SFB 1116 B08]
- Hans und Gertie Fischer Foundation
- Dr. Deichmann Foundation
- EU [COST Action CA16225]
Remote ischemic preconditioning (RIPC) by repeated brief cycles of limb ischemia/reperfusion may reducemyocardial ischemia/reperfusion injury and improve patients prognosis after elective coronary artery bypass graft (CABG) surgery. The signal transducer and activator of transcription (STAT) 5 activation in left ventricular myocardium is associated with RIPC's cardioprotection. Cytokines and growth hormones typically activate STATs and could therefore act as humoral transfer factors of RIPC's cardioprotection. We here determined arterial plasma concentrations of 25 different cytokines, growth hormones, and other factors which have previously been associated with cardioprotection, before (baseline)/after RIPC or placebo (n = 23/23), respectively, and before/after ischemic cardioplegic arrest in CABG patients. RIPC induced protection was reflected by a 35% reduction of serum troponin I release. With the exception of interleukin-1 alpha, none of the humoral factors changed in their concentrations after RIPC or placebo, respectively. Interleukin-1 alpha, when normalized to baseline, increased after RIPC (280 +/- 56%) but not with placebo (97 +/- 15%). The interleukin-1 alpha concentration remained increased until after ischemic cardioplegic arrest and was also higher than with placebo in absolute concentrations (25 +/- 6 versus 16 +/- 3 pg/mL). Only interleukin-1 alpha possibly fulfills the criteria which would be expected from a substance to be released in response to RIPC and to protect the myocardium during ischemic cardioplegic arrest.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据